Open AccessInterleukin-6 and C-reactive protein levels after 3 years of treatment with darunavir/ritonavir monotherapy or darunavir/ritonavir + two nucleoside reverse transcriptase inhibitors in the MONET trial
Author(s) -
José Ramón Arribas,
Andrew F. Hill,
Ning Xi,
Yvon van Delft,
Christiane Moecklinghoff
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks102
Subject(s) - darunavir , ritonavir , medicine , nucleoside reverse transcriptase inhibitor , pharmacology , virology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom